Trials / Unknown
UnknownNCT03439904
Individualized Pharmaceutical-care in Outpatients With Cancer Pain
Impact of Individualized Pharmaceutical-care on Medication Adherence and Outcome of Cancer Pain in Opioid-tolerant Outpatients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Zhejiang Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients
Detailed description
This study is a prospective multicenter randomized controlled study to investigate the impact of pharmaceutical care on cancer pain treatment for opioid-tolerant outpatients treated with sustained released morphine, oxycodone, and transdermal fentanyl.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Pharmaceutical care | Patients receive pharmaceutical care including individualized evaluation and intervention of adherence, efficacy and safety in cancer pain treatment. |
Timeline
- Start date
- 2018-06-30
- Primary completion
- 2019-06-30
- Completion
- 2019-06-30
- First posted
- 2018-02-20
- Last updated
- 2019-01-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03439904. Inclusion in this directory is not an endorsement.